icon star paper   Hepatitis B Articles (HBV)  
Back grey_arrow_rt.gif
 
 
Sustained reduction of HBV DNA, RNA and proteins, and HBeAg seroconversion in a chronically HBV-infected chimpanzee treated with nucleoside analog/ARC-520 combination therapy
 
 
  Reported by Jules Levin
HEPDART 2015
December 6-10, 2015 Wailea, HI
 
Christine I. Wooddell1, Deborah Chavez2, Jason E. Goetzmann3, Ryan M. Peterson1, Zhao Xu1, Robert G. Gish4,5, Stephen A. Locarnini6, Christopher R. Anzalone1, Robert E. Lanford2 and David L. Lewis1
1 Arrowhead Research Corporation, Madison, WI; 2 Texas Biomedical Research Institute, San Antonio, TX; 3 University of Louisiana, Lafayette, LA; 4 Stanford University Medical Center, Palo Alto, CA;
5 Hepatitis B Foundation, Doylestown, PA; 6 Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif

AASLD13.gif

AASLD14.gif

 
 
 
 
  icon paper stack View Older Articles   Back to Top   www.natap.org